Modular Medical Makes Progress Towards CE Mark Certification in 2026
ByAinvest
Tuesday, Oct 28, 2025 8:37 am ET1min read
MODD--
Modular Medical is progressing towards CE Mark certification under the European Union Medical Device Regulation for its Pivot insulin delivery system. The company completed its Stage 1 ISO 13485:2016 audit with no major nonconformities identified and plans to advance to its Stage 2 audit in early 2026. Successful completion of these steps is required for Modular Medical's planned commercial launch in the European Union.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet